NL-OMON24454尚未招募不适用
The value of a risk prediction tool (PERSARC) for effective treatment decisions of soft tissue sarcomas patients: a stepped wedge Randomized Controlled Trial.
KWF kankerbestrijding0 个研究点目标入组 231 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 231
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients (>= 18 years) with primarily diagnosed (histologically confirmed) grade 2-3 extremity STS, who do not have a treatment plan yet and will be treated with curative intent. Patients with sarcoma subtypes or treatment options other than those mentioned in the PERSARC app are unable to participate. Furthermore, patients need to be Dutch fluency and literacy and mentally competent.
排除标准
- •Patient that are treated without curative intent
- •Patient that needs to be treated with chemotherapy or isolated limb perfusion
- •Patients were surgery is not indicated
- •Sarcoma subtypes not mentioned in the PERSARC app
研究者
相似试验
招募中
不适用
The value of a risk prediction tool (PERSARC) for effectvie treatment decision making: a stepped wedge Randomized Controlled Trial.soft tissue extremity sarcomas10041297NL-OMON51872eids Universitair Medisch Centrum120
进行中（未招募）
不适用
The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas PatientsSoft-tissue SarcomaPredictive Cancer ModelNCT05741944Leiden University Medical Center120
尚未招募
不适用
A risk-predictive score for developing Non-Alcoholic Fatty Liver Disease (NAFLD) using biochemical markersCTRI/2022/12/048328PG Grants, Kasturba Medical College
招募中
不适用
*The PreRisk calculator in suspected or confirmed preeclampsia: A new tool to safely reduce the number of unnecessary admissions*NL-OMON48687Erasmus MC, Universitair Medisch Centrum Rotterdam864
招募中
不适用
The PreRisk calculator in suspected or confirmed preeclampsia: A new tool to safely reduce the number of unnecessary admissions’NL-OMON22891one864